Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity
Giulia Angelini(Università Cattolica del Sacro Cuore), Geltrude Mingrone(University of the Sacred Heart), Maria Emiliana Caristo(Università Cattolica del Sacro Cuore), Pier Luigi Marini(Carlo Forlanini Hospital), Gianluigi Stefanizzi(Università Cattolica del Sacro Cuore), Maria Francesca Russo(Sapienza University of Rome), Stefan R. Bornstein(King's College London), Giovanni Casella(Sapienza University of Rome), Ornella Verrastro(Agostino Gemelli University Polyclinic), James Casella-Mariolo(ASL Roma), Lidia Castagneto‐Gissey(Policlinico Umberto I), Erminia Lembo(Università Cattolica del Sacro Cuore), Francesco Rubino(King's College Hospital)
American Journal of Physiology-Gastrointestinal and Liver Physiology
August 19, 2020
Cited by 14
Related Papers
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
|The Journal of Clinical Endocrinology & Metabolism|2016|1.7k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.5k
Joint international consensus statement for ending stigma of obesity
|Nature Medicine|2020|1.1k